Currently, there are 1.34B common shares owned by the public and among those 1.32B shares have been available to trade.
Insiders at the company have transacted a total of 273 times over the past 12 months, according to data filed with the U.S. Securities and Exchange Commission (SEC). 36 of these insider trades were purchases, accounting for 1,546,736 shares. Insider sales of the common stock occurred on 237 occasions, with total insider shares sold totaling 14,400,234 shares.
3 Tiny Stocks Primed to Explode
The world's greatest investor — Warren Buffett — has a simple formula for making big money in the markets. He buys up valuable assets when they are very cheap. For stock market investors that means buying up cheap small cap stocks like these with huge upside potential.
We've set up an alert service to help smart investors take full advantage of the small cap stocks primed for big returns.
Click here for full details and to join for free
Sponsored
The company’s stock has a 5-day price change of -1.55% and -6.62% over the past three months. DNA shares are trading -24.85% year to date (YTD), with the 12-month market performance down to -36.50% lower. It has a 12-month low price of $1.12 and touched a high of $2.55 over the same period. DNA has an average intraday trading volume of 21.59 million shares. The stock is trading above its simple moving averages at the SMA20, SMA50, and SMA200, as the current price level is off by -3.64%, -11.74%, and -23.21% respectively.
Institutional ownership of Ginkgo Bioworks Holdings Inc (NYSE: DNA) shares accounts for 61.40% of the company’s 1.34B shares outstanding.
It has a market capitalization of $2.54B and a beta (3y monthly) value of 1.30. The earnings-per-share (ttm) stands at -$0.45. Price movements for the stock have been influenced by the stock’s volatility, which stands at 8.39% over the week and 7.45% over the month.
Analysts forecast that Ginkgo Bioworks Holdings Inc (DNA) will achieve an EPS of $Ginkgo Bioworks Holdings, Inc. for the current quarter, $1.27 for the next quarter and $Stocks for Type. The lowest estimate earnings-per-share for the quarter is $Direxion Small Cap Bull 3X Shar while analysts give the company a high EPS estimate of $SPDR Dow Jones Industrial Avera. Comparatively, EPS for the current quarter was $Denison Mines Corp a year ago. Earnings per share for the fiscal year are expected to increase by 64.80%, and 31.82% over the next financial year.
Looking at the support for the DNA, a number of firms have released research notes about the stock. Raymond James stated their Mkt Perform rating for the stock in a research note on November 14, 2023, with the firm’s price target at $3.50-$2.50.
